SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-055674
Filing Date
2020-05-01
Accepted
2020-05-01 17:26:15
Documents
12
Period of Report
2020-04-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2018409d1_8k.htm   iXBRL 8-K 25848
  Complete submission text file 0001104659-20-055674.txt   199456

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA akrx-20200427.xsd EX-101.SCH 3177
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE akrx-20200427_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akrx-20200427_pre.xml EX-101.PRE 22704
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2018409d1_8k_htm.xml XML 3587
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32360 | Film No.: 20841962
SIC: 2834 Pharmaceutical Preparations